Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Clinical trial NCT03859141 · COMPLETED

Trial details

NCT number: NCT03859141
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2018-02-06
Primary completion: 2018-04-17
Enrollment: 2340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.